# OnCo record amplia-therapeutics (company). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/companies/amplia-therapeutics/>
  a schema:Organization ;
  onco:kind "company" ;
  schema:identifier "amplia-therapeutics" ;
  schema:name "Amplia Therapeutics"@en ;
  schema:alternateName "Amplia Therapeutics Limited"@en ;
  schema:description "Amplia Therapeutics is an Australia-based biotechnology company that leads 2 cancer trials in OnCo, testing the focal adhesion kinase inhibitor narmafotinib (AMP945) in pancreatic ductal adenocarcinoma."@en ;
  schema:url <https://onco.cc/companies/amplia-therapeutics/>, <https://www.ampliatx.com/> ;
  schema:dateModified "2026-09-17"^^xsd:date ;
  schema:citation <https://www.ampliatx.com/>, <https://clinicaltrials.gov/search?lead=Amplia%20Therapeutics%20Limited> ;
  onco:tag "ctgov-sponsor" ;
  schema:addressCountry "AU" ;
  onco:cancers <https://onco.cc/cancers/pancreatic/> ;
  onco:trials <https://onco.cc/trials/nct07026279/>, <https://onco.cc/trials/nct05355298/> .